vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and Westrock Coffee Co (WEST). Click either name above to swap in a different company.
Westrock Coffee Co is the larger business by last-quarter revenue ($339.5M vs $208.9M, roughly 1.6× iRhythm Holdings, Inc.). iRhythm Holdings, Inc. runs the higher net margin — 2.7% vs -6.6%, a 9.3% gap on every dollar of revenue. On growth, Westrock Coffee Co posted the faster year-over-year revenue change (48.3% vs 27.1%). Westrock Coffee Co produced more free cash flow last quarter ($27.8M vs $14.5M). Over the past eight quarters, Westrock Coffee Co's revenue compounded faster (32.8% CAGR vs 25.8%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Westrock Coffee Co is a global integrated coffee, tea and functional beverage solutions provider. It sources, roasts, manufactures and distributes coffee products, ready-to-drink beverages and custom formulations for retail, foodservice and commercial clients across North America and other key markets.
IRTC vs WEST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $339.5M |
| Net Profit | $5.6M | $-22.6M |
| Gross Margin | 70.9% | 11.5% |
| Operating Margin | 1.1% | -2.6% |
| Net Margin | 2.7% | -6.6% |
| Revenue YoY | 27.1% | 48.3% |
| Net Profit YoY | 518.5% | 8.3% |
| EPS (diluted) | $0.18 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $339.5M | ||
| Q3 25 | $192.9M | $354.8M | ||
| Q2 25 | $186.7M | $280.9M | ||
| Q1 25 | $158.7M | $213.8M | ||
| Q4 24 | $164.3M | $229.0M | ||
| Q3 24 | $147.5M | $220.9M | ||
| Q2 24 | $148.0M | $208.4M | ||
| Q1 24 | $131.9M | $192.5M |
| Q4 25 | $5.6M | $-22.6M | ||
| Q3 25 | $-5.2M | $-19.1M | ||
| Q2 25 | $-14.2M | $-21.6M | ||
| Q1 25 | $-30.7M | $-27.2M | ||
| Q4 24 | $-1.3M | $-24.6M | ||
| Q3 24 | $-46.2M | $-14.3M | ||
| Q2 24 | $-20.1M | $-17.8M | ||
| Q1 24 | $-45.7M | $-23.7M |
| Q4 25 | 70.9% | 11.5% | ||
| Q3 25 | 71.1% | 11.7% | ||
| Q2 25 | 71.2% | 14.7% | ||
| Q1 25 | 68.8% | 13.6% | ||
| Q4 24 | 70.0% | 16.6% | ||
| Q3 24 | 68.8% | 16.8% | ||
| Q2 24 | 69.9% | 19.9% | ||
| Q1 24 | 66.3% | 19.4% |
| Q4 25 | 1.1% | -2.6% | ||
| Q3 25 | -4.4% | -2.4% | ||
| Q2 25 | -10.0% | -5.3% | ||
| Q1 25 | -20.5% | -6.1% | ||
| Q4 24 | -2.5% | -4.3% | ||
| Q3 24 | -34.1% | -5.8% | ||
| Q2 24 | -15.5% | -7.9% | ||
| Q1 24 | -28.9% | -5.3% |
| Q4 25 | 2.7% | -6.6% | ||
| Q3 25 | -2.7% | -5.4% | ||
| Q2 25 | -7.6% | -7.7% | ||
| Q1 25 | -19.3% | -12.7% | ||
| Q4 24 | -0.8% | -10.7% | ||
| Q3 24 | -31.3% | -6.5% | ||
| Q2 24 | -13.6% | -8.5% | ||
| Q1 24 | -34.6% | -12.3% |
| Q4 25 | $0.18 | $-0.22 | ||
| Q3 25 | $-0.16 | $-0.20 | ||
| Q2 25 | $-0.44 | $-0.23 | ||
| Q1 25 | $-0.97 | $-0.29 | ||
| Q4 24 | $-0.03 | $-0.26 | ||
| Q3 24 | $-1.48 | $-0.16 | ||
| Q2 24 | $-0.65 | $-0.20 | ||
| Q1 24 | $-1.47 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $49.9M |
| Total DebtLower is stronger | — | $444.1M |
| Stockholders' EquityBook value | $152.7M | $-1.9M |
| Total Assets | $1.0B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $49.9M | ||
| Q3 25 | $565.2M | $34.0M | ||
| Q2 25 | $545.5M | $44.0M | ||
| Q1 25 | $520.6M | $33.1M | ||
| Q4 24 | $535.6M | $26.2M | ||
| Q3 24 | $522.0M | $22.4M | ||
| Q2 24 | $561.5M | $24.3M | ||
| Q1 24 | $569.1M | $12.6M |
| Q4 25 | — | $444.1M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $393.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $152.7M | $-1.9M | ||
| Q3 25 | $121.9M | $11.4M | ||
| Q2 25 | $103.7M | $18.2M | ||
| Q1 25 | $86.7M | $71.4M | ||
| Q4 24 | $90.9M | $97.5M | ||
| Q3 24 | $71.8M | $110.3M | ||
| Q2 24 | $99.2M | $81.5M | ||
| Q1 24 | $90.3M | $91.7M |
| Q4 25 | $1.0B | $1.2B | ||
| Q3 25 | $995.2M | $1.2B | ||
| Q2 25 | $964.0M | $1.2B | ||
| Q1 25 | $926.1M | $1.1B | ||
| Q4 24 | $931.4M | $1.1B | ||
| Q3 24 | $909.7M | $1.1B | ||
| Q2 24 | $919.2M | $1.1B | ||
| Q1 24 | $909.8M | $983.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.03× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $36.7M |
| Free Cash FlowOCF − Capex | $14.5M | $27.8M |
| FCF MarginFCF / Revenue | 6.9% | 8.2% |
| Capex IntensityCapex / Revenue | 5.6% | 2.6% |
| Cash ConversionOCF / Net Profit | 4.70× | — |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $-107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $36.7M | ||
| Q3 25 | $34.9M | $-26.6M | ||
| Q2 25 | $27.7M | $-7.0M | ||
| Q1 25 | $-7.9M | $-22.1M | ||
| Q4 24 | $19.2M | $2.8M | ||
| Q3 24 | $24.3M | $-332.0K | ||
| Q2 24 | $11.8M | $-23.7M | ||
| Q1 24 | $-52.0M | $8.0M |
| Q4 25 | $14.5M | $27.8M | ||
| Q3 25 | $20.1M | $-44.7M | ||
| Q2 25 | $17.3M | $-27.5M | ||
| Q1 25 | $-17.3M | $-63.4M | ||
| Q4 24 | $12.4M | $-15.4M | ||
| Q3 24 | $15.5M | $-36.7M | ||
| Q2 24 | $3.4M | $-59.9M | ||
| Q1 24 | $-61.8M | $-60.9M |
| Q4 25 | 6.9% | 8.2% | ||
| Q3 25 | 10.4% | -12.6% | ||
| Q2 25 | 9.3% | -9.8% | ||
| Q1 25 | -10.9% | -29.7% | ||
| Q4 24 | 7.5% | -6.7% | ||
| Q3 24 | 10.5% | -16.6% | ||
| Q2 24 | 2.3% | -28.7% | ||
| Q1 24 | -46.8% | -31.7% |
| Q4 25 | 5.6% | 2.6% | ||
| Q3 25 | 7.7% | 5.1% | ||
| Q2 25 | 5.6% | 7.3% | ||
| Q1 25 | 5.9% | 19.3% | ||
| Q4 24 | 4.2% | 7.9% | ||
| Q3 24 | 6.0% | 16.5% | ||
| Q2 24 | 5.7% | 17.4% | ||
| Q1 24 | 7.4% | 35.8% |
| Q4 25 | 4.70× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
